docetaxel has been researched along with vincristine in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (33.33) | 29.6817 |
2010's | 6 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Afragola, J; Ayral-Kaloustian, S; Beyer, C; Gibbons, J; Hernandez, R; Lucas, J; Nguyen, T; Zhang, N | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Benfenati, E; Raska, I; Toropov, AA; Toropova, AP | 1 |
Dahlén, K; Dyrager, C; Friberg, A; Fridén-Saxin, M; Grøtli, M; Gullbo, J; Luthman, K; Wallén, EA; Wickström, M | 1 |
Bennani, YL; Canales, A; Díaz, FJ; Eustace, BK; Gu, W; Hoover, RR; Jiménez-Barbero, J; Nezami, A; Wang, T | 1 |
Baldeyrou, B; Berthelot, P; Farce, A; Flouquet, N; Goossens, JF; Lansiaux, A; Lebegue, N; Lecoeur, M; Lemoine, A; Mahieu, C; Verones, V; Wattez, N | 1 |
Akula, B; Bharathi, EV; Billa, VK; Cosenza, SC; Gallo, JM; Lv, H; Mallireddigari, MR; Padgaonkar, A; Pallela, VR; Reddy, EP; Reddy, MV; Subbaiah, DR | 1 |
9 other study(ies) available for docetaxel and vincristine
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Synthesis and SAR of [1,2,4]triazolo[1,5-a]pyrimidines, a class of anticancer agents with a unique mechanism of tubulin inhibition.
Topics: Administration, Oral; Animals; Cell Proliferation; Female; Humans; Injections, Intravenous; Mice; Mice, Nude; Pyrimidines; Stereoisomerism; Structure-Activity Relationship; Triazoles; Tubulin Modulators; Xenograft Model Antitumor Assays | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
QSPR modeling of octanol/water partition coefficient of antineoplastic agents by balance of correlations.
Topics: Antineoplastic Agents; Models, Chemical; Octanols; Quantitative Structure-Activity Relationship; Water | 2010 |
Inhibitors and promoters of tubulin polymerization: synthesis and biological evaluation of chalcones and related dienones as potential anticancer agents.
Topics: Antineoplastic Agents; Binding Sites; Cell Line, Tumor; Chalcones; Drug Screening Assays, Antitumor; Humans; Ketones; Polymerization; Structure-Activity Relationship; Tubulin; Tubulin Modulators | 2011 |
Tubulin binding, protein-bound conformation in solution, and antimitotic cellular profiling of noscapine and its derivatives.
Topics: Aniline Compounds; Antineoplastic Agents; Binding Sites; Cell Line, Tumor; Cell Survival; Crystallography, X-Ray; Drug Screening Assays, Antitumor; Fluorescence; Humans; Magnetic Resonance Spectroscopy; Molecular Conformation; Noscapine; Protein Binding; Solutions; Structure-Activity Relationship; Tubulin; Tubulin Modulators | 2012 |
Synthesis, antiproliferative activity and tubulin targeting effect of acridinone and dioxophenothiazine derivatives.
Topics: Acridones; Antineoplastic Agents; Cell Proliferation; Drug Delivery Systems; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Phenothiazines; Structure-Activity Relationship; Tubulin; Tumor Cells, Cultured | 2013 |
Design, synthesis, and biological evaluation of (E)-N-aryl-2-arylethenesulfonamide analogues as potent and orally bioavailable microtubule-targeted anticancer agents.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Biological Availability; Blood-Brain Barrier; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Survival; Drug Design; Drug Resistance, Neoplasm; HCT116 Cells; Humans; K562 Cells; MCF-7 Cells; Mice; Mice, Nude; Microtubules; Neoplasms; Polymerization; Sulfonamides; Tubulin; Tumor Burden; Xenograft Model Antitumor Assays | 2013 |